179 related articles for article (PubMed ID: 23109831)
1. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
[TBL] [Abstract][Full Text] [Related]
2. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
3. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
4. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
[TBL] [Abstract][Full Text] [Related]
5. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
[TBL] [Abstract][Full Text] [Related]
6. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.
Mandal RK; Nissar K; Mittal RD
Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000
[TBL] [Abstract][Full Text] [Related]
8. The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies.
Zhang Y; Yang D; Zhu JH; Chen MB; Shen WX; He J
Cancer Invest; 2015 Mar; 33(2):39-40. PubMed ID: 25608636
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study.
Yang S; Zhao J; Li L
Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295
[TBL] [Abstract][Full Text] [Related]
10. An association between a NQO1 genetic polymorphism and risk of lung cancer.
Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
[TBL] [Abstract][Full Text] [Related]
11. Association between NQO1 C609T polymorphism and colorectal cancer risk.
Wang Y; Zhang G; Luo Y
Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
[TBL] [Abstract][Full Text] [Related]
12. Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.).
Lienhart WD; Gudipati V; Uhl MK; Binter A; Pulido SA; Saf R; Zangger K; Gruber K; Macheroux P
FEBS J; 2014 Oct; 281(20):4691-4704. PubMed ID: 25143260
[TBL] [Abstract][Full Text] [Related]
13. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
[TBL] [Abstract][Full Text] [Related]
15. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis.
Liu Y; Zhang D
Asian Pac J Cancer Prev; 2011; 12(11):3091-5. PubMed ID: 22393995
[TBL] [Abstract][Full Text] [Related]
16. 609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.
Steiner M; Hillenbrand M; Borkowsi M; Seiter H; Schuff-Werner P
Cancer Lett; 1999 Jan; 135(1):67-71. PubMed ID: 10077223
[TBL] [Abstract][Full Text] [Related]
17. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
18. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
19. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
20. Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis.
Abedinzadeh M; Moghimi M; Dastgheib SA; Maleki H; Salehi E; Zare M; Jarahzadeh HM; Neamatzadeh H
Klin Onkol; 2020; 33(2):92-100. PubMed ID: 32303129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
